More Genetic Signatures Ltd. news
Genetic Signatures Ltd.ASX: GSS

STI Detection Kit Clinical Validation Trial Results

Oct 18, 2016 at 1:42 AM EDT · Issued by Genetic Signatures Ltd.

Filed with ASX · Oct 18, 2016 at 1:42 AM EDT · 3 pages · English

On 6ix: 6ix.com/news/sti-detection-kit-clinical-validation-trial-results

Watch Genetic Signatures' latest callGenetic Signatures (ASX:GSS) Q4 2026 Earnings Call · Replay · Aug 25↗

Genetic Signatures Ltd. on 6ix

In the deck

  • Genetic Signatures — 7th Annual Australian Microcap Investment Conference 201634 slidesOct 18, 2016

Earlier from Genetic Signatures

  • Open Briefing - Capital Raising and Company OutlookSep 28, 2016
  • Clinical Validation of Sexual Health Detection Kit CommencedSep 26, 2016
  • Completion of $14m capital raisingSep 1, 2016
  • UCLA to launch Genetic Signatures technologyJun 23, 2016
  • GSS launches Analyte Specific Reagents in USJun 16, 2016

Later from Genetic Signatures

  • 2016 AGM MD and CEO PresentationNov 28, 2016
  • Appendix 4D - Half Yearly Report and AccountsFeb 26, 2017
  • GSS Launches Sexually Transmitted Infection (STI) KitMar 30, 2017
  • Results of Flavivirus Clinical TrialApr 23, 2017
  • Regulatory and Patent approvalJun 19, 2017
All Genetic Signatures news releases↗

Follow Genetic Signatures into a list and get an email when it puts out news.

Follow Genetic Signatures
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer